TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $25,000 | -7.4% | 1,509 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $27,000 | 0.0% | 1,509 | 0.0% | 0.01% | +16.7% |
| Q4 2020 | $27,000 | -22.9% | 1,509 | -25.0% | 0.01% | -33.3% |
| Q3 2020 | $35,000 | -2.8% | 2,012 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $36,000 | +20.0% | 2,012 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $30,000 | -33.3% | 2,012 | -12.6% | 0.01% | -10.0% |
| Q4 2019 | $45,000 | +15.4% | 2,303 | 0.0% | 0.01% | +11.1% |
| Q3 2019 | $39,000 | -9.3% | 2,303 | -6.9% | 0.01% | -10.0% |
| Q2 2019 | $43,000 | +7.5% | 2,474 | +13.6% | 0.01% | +11.1% |
| Q1 2019 | $40,000 | – | 2,177 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |